期刊
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
卷 10, 期 6, 页码 -出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1756285617708911
关键词
lesion; McDonald criteria; magnetic resonance imaging; multiple sclerosis; no evidence of disease activity; treatment efficacy
资金
- Biogen
- Novartis Pharmaceuticals
- Mallinckrodt
- Genzyme
Magnetic resonance imaging (MRI) has developed into the most important tool for the diagnosis and monitoring of multiple sclerosis (MS). Its high sensitivity for the evaluation of inflammatory and neurodegenerative processes in the brain and spinal cord has made it the most commonly used technique for the evaluation of patients with MS. Moreover, MRI has become a powerful tool for treatment monitoring, safety assessment as well as for the prognostication of disease progression. Clinically, the use of MRI has increased in the past couple decades as a result of improved technology and increased availability that now extends well beyond academic centers. Consequently, there are numerous studies supporting the role of MRI in the management of patients with MS. The aim of this review is to summarize the latest insights into the utility of MRI in MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据